Armstrong Advisory Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45
| Closed | -$604 | – | 849 |
|
|
2024
Q1 | $604 | Hold |
45
| – | – | ﹤0.01% | 746 |
|
|
2023
Q4 | $604 | Hold |
45
| – | – | ﹤0.01% | 746 |
|
|
2023
Q3 | $555 | Hold |
45
| – | – | ﹤0.01% | 813 |
|
|
2023
Q2 | $554 | Hold |
45
| – | – | ﹤0.01% | 778 |
|
|
2023
Q1 | $554 | Hold |
45
| – | – | ﹤0.01% | 759 |
|
|
2022
Q4 | $516 | Buy |
+45
| New | +$516 | ﹤0.01% | 783 |
|